graves ophthalmopathy
Showing NaN - NaN of 1
Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)
Recruiting
- Graves Ophthalmopathy
- Tocilizumab 20 Mg/mL Intravenous Solution
- MethylPREDNISolone Injectable Solution
-
Milano, MI, Italy
- +3 more
Aug 3, 2022